DOCSLIB.ORG

[Thesis Title Goes Here]

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
[Thesis Title Goes Here] PET/MR IMAGING OF ATHEROSCLEROTIC PLAQUE AND TUMOR USING DUAL MODALITY SPIOS A Dissertation Presented to The Academic Faculty by Nazanin Masoodzadehgan In Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the School of Engineering Georgia Institute of Technology December 2014 Copyright © Nazanin Masoodzadehgan 2014 PET/MR IMAGING OF ATHEROSCLEROTIC PLAQUE AND TUMOR USING DUAL MODALITY SPIOS Approved by: Dr. Gang Bao, Ph.D., Advisor Dr. Mark Goodman, Ph.D. Department of Biomedical Engineering Department of Radiology and Imaging Georgia Institute of Technology and Emory Sciences University Emory University Dr. Yongjian Liu, Ph.D. Dr. Hui Mao, Ph.D. Department of Radiology Department of Radiology and Imaging Washington University School of Medicine Sciences Emory University Dr. Farzad Rahnema, Ph.D. Dr. W. Robert Taylor, MD, Ph.D. Department of Mechanical Engineering Department of Cardiology Georgia Institute of Technology Emory University, Georgia Institute of Technology and Atlanta VA Date Approved: July 29th, 2014 DEDICATION To loving memory of my father Bahram Hoshyar, my mother Nasrin and my brothers Yousef and Behnam. & My husband Ata iii ACKNOWLEDGEMENTS I am extremely grateful to my thesis advisor Professor Gang Bao for the opportunity to participate in this research. His patience and guidance as an advisor and mentor have been invaluable. I would like to thank the members of my thesis committee, Dr. Mark Goodman, Dr. Yongjian Liu, Dr. Hui Mao, Dr. Farzad Rahnema, and Dr. Robert Taylor for their time and instruction. To the past and present members of Bao Lab, thank you for the foundation you have built and for your help with this research. In particular, I would like to thank Dr. Sheng Tong and Dr. Sijian Hue for being available to answer my many coating questions. This work would have been much more difficult without Dr. Johaness Leisen’s help in performing MRI. I also like to thank Annie Zheng for her help with cell culture and microscopy. Also I like to thank Amy Tang for her support. I am grateful to Erin Kirshtein for her support and wonderful spirit. I also thank Dr. Charlie Glaus for his help in answering my conjugation questions. I thank Sally Gerrish for her help with career search. I also thank Glenda Johnson for her advise on graduate studies. I especially thank Dr. Wone Woo Seo for all his help and support at Wesley Woods. This dissertation would not be completed without Wone Woo’s help. I also thank the members of Dr. Goodman’s group, especially Dr. Voll for always being helpful. Also, I thank Mel Kemp, Larry Williams, and Eugene Malveaux for their help with biodistribution studies. Also, I thank Aaron Smith for his help with autoradiography. I am also thankful to Dr. Jon Nye for his help with PET imaging and teaching me image analysis. I also thank Margie Jones and Dr. Jaekun Park for her help with PET imaging. iv I especially thank members of Dr. Taylors group, Diana Weiss, Sarah Knight and Jane Titterington. Also, I thank Dr. Liu’s research group, Hannah and Debbie. I am grateful to Liya Wang for her help with preparing the 4T1 animal model. I also thank Dr. Ravi Bellamkonda for being a great mentor and his efforts in conducting the graduate leadership program. I also thank Dr. Garmestani for always being supportive and kind. I thank my undergraduate students, Needa Virani, Arsalan Saboori, and Samantha Gray for their outstanding work. I also thank Nassir Mokarram for his help and advice regarding chemistry and conjugation issues and for his friendship. Finally, I would like to thank my family for all their support during the past six years. I especially like to thank my husband Ata for his love, support and understanding. v TABLE OF CONTENTS DEDICATION................................................................................................................. III ACKNOWLEDGEMENTS ........................................................................................... IV LIST OF FIGURES ..................................................................................................... VIII LIST OF SYMBOLS AND ABBREVIATIONS ........................................................... X SUMMARY ..................................................................................................................... XI CHAPTER 1: DUAL MODALITY PET/MR CONTRAST AGENT .......................... 1 Nanoparticles for PET/MR Imaging ............................................................................... 1 SPIO Synthesis................................................................................................................ 3 SPIO Characterization .................................................................................................... 5 64Cu Radiolabeling, Characterization and Serum Stability............................................. 6 Discussion and Conclusion ............................................................................................. 9 References ..................................................................................................................... 11 CHAPTER 2: EFFECT OF SIZE ON NANOPARTICLE PHARMACOKINETICS AND BIODISTRIBUTION ............................................................................................ 13 Trends in vitro ........................................................................................................................... 14 Cellular Uptake .......................................................................................................................... 14 Active Targeting ........................................................................................................................ 18 Trends in vivo ............................................................................................................................ 20 Pharmacokinetics of 6nm and 14nm SPIOs .............................................................................. 24 Biodistribution studies of 6 nm and 14 nm SPIOs .................................................................... 27 Discussion and Conclusion ........................................................................................................ 32 References ................................................................................................................................. 33 Chapter 3: IN VIVO IMAGING OF EARLY STAGE ATHEROSCLEROTIC PLAQUES ........................................................................................................................ 38 Atherosclerosis .......................................................................................................................... 38 VCAM1 Targeting ..................................................................................................................... 39 Plaque Imaging .......................................................................................................................... 42 In Vitro Targeting Studies ......................................................................................................... 44 Phantom Studies ........................................................................................................................ 45 Carotid Ligation Model ............................................................................................................. 46 In vivo and Ex vivo imaging using DiR labeled SPIOs ............................................................ 47 vi In vivo PET/CT imaging using 64Cu-VINP-SPIOs ................................................................... 49 Discussion and Conclusion ........................................................................................................ 51 References ................................................................................................................................. 53 CHAPTER 4: TUMOR IMAGING .............................................................................. 55 In vivo imaging of 4T1 Tumor .................................................................................................. 56 Surface coating and functionalizing 64Cu-CD105 Targeted SPIOs ........................................... 60 Phantom Studies ........................................................................................................................ 64 Radiolabeling and characterization ........................................................................................... 65 4T1 Tumor Model ..................................................................................................................... 66 PET Imaging and Biodistribution studies of CD105 Targeted SPIOs....................................... 67 In vivo MR imaging using 64Cu-CD105-SPIOs ........................................................................ 70 Discussion and Conclusion ........................................................................................................ 71 References ................................................................................................................................. 74 CHAPTER 5: CONCLUSIONS AND FUTURE CHALLENGES ............................ 77 APPENDIX A: ................................................................................................................. 81 APPENDIX B: ................................................................................................................. 82 CURRICULUM VITA ..................................................................................................
Load more

Recommended publications
  • The Use of Bubble CPAP in Premature Infants: Local Experience
    HK J Paediatr (new series) 2007;12:86-92 The Use of Bubble CPAP in Premature Infants: Local Experience KM CHAN, HB CHAN Abstract Bubble continuous positive airway pressure (CPAP) was introduced more than 30 years ago for infants with respiratory distress. With this, there had been reports of decreased incidence of mechanical ventilation and chronic lung disease among the premature, as well as less failure of extubation. This report described how this treatment modality was adopted locally and showed it might be associated with less apnoea among very low birth weight (VLBW) and extremely low birth weight (ELBW) infants post extubation with improved non-pulmonary outcomes. Key words Apnoea of prematurity; Bubble CPAP; Chronic lung Disease; ELBW babies; VLBW babies Introduction device. Pressure can be generated from the following three ways.4 Continuous positive airway pressure (CPAP) is a method Firstly, the expiratory valve of the ventilator is used to of delivering positive end-expiratory pressure with a adjust the expiratory pressure. Secondly, the pressure is variable amount of oxygen to the airway of a spontaneously generated by adjusting the inspiratory flow or altering the breathing patient to maintain lung volume during expiration, expiratory resistance (e.g. Infant Flow Nasal CPAP system, so as to reduce atelectasis, respiratory fatigue and to VIASYS Healthcare, Inc. USA). Thirdly, the bubble CPAP improve oxygenation. It was first reported in 1971 for system produces a positive pressure by placing the far end supporting breathing of preterm neonates.1 Clinical benefits of the expiratory tubing under water. The pressure is have been associated with the use of CPAP in the premature adjusted by altering the depth of the tube under the surface newborn.
    [Show full text]
  • A Pilot Study of Improvised CPAP (Icpap) Via Face Mask for the Treatment of Adult Respiratory Distress in Low-Resource Settings Brendan H
    Milliner et al. International Journal of Emergency Medicine (2019) 12:7 International Journal of https://doi.org/10.1186/s12245-019-0224-0 Emergency Medicine PRACTICE INNOVATIONS IN EMERGENCY MEDICINE Open Access A pilot study of improvised CPAP (iCPAP) via face mask for the treatment of adult respiratory distress in low-resource settings Brendan H. Milliner1* , Suzanne Bentley2,3 and James DuCanto4 Abstract Background: Continuous positive airway pressure (CPAP) is a mode of non-invasive ventilation used to treat a variety of respiratory conditions in the emergency department and intensive care unit. In low-resource settings where ventilators are not available, the ability to improvise a CPAP system from locally available equipment would provide a previously unavailable means of respiratory support for patients in respiratory distress. This manuscript details the design of such a system and its performance in healthy volunteers. Methods: An improvised CPAP system was assembled from standard emergency department equipment and tested in 10 healthy volunteers (6 male, 4 female; ages 29–33). The system utilizes a water seal and high-flow air to create airway pressure; it was set to provide a pressure of 5 cmH2O for the purposes of this pilot study. Subjects used the system in a monitored setting for 30 min. Airway pressure, heart rate, oxygen saturation, and end-tidal CO2 were monitored. Comfort with the device was assessed via questionnaire. Results: The system maintained positive airway pressure for the full trial period in all subjects, with a mean expiratory pressure (EP) of 5.1 cmH2O (SD 0.7) and mean inspiratory pressure (IP) of 3.2 cmH2O (SD 0.8).
    [Show full text]
  • Bubble Bilevel Ventilation Facilitates Gas Exchange in Anesthetized Rabbits
    www.nature.com/pr CLINICAL RESEARCH ARTICLE Bubble bilevel ventilation facilitates gas exchange in anesthetized rabbits Stephen C. John1, Azmath Mohammed2, Joseph T. Church1, Anna V. John1, Elena M. Perkins1, Jennifer S. McLeod1, Benjamin D. Carr1, Sue Smith1, J. Hudson Barnett3, Peter A. Gustafson3, Macdonald Dick1 and Sunil P. John1 BACKGROUND: Bubble continuous positive airway pressure is an established therapy for infants in respiratory distress. In resource- limited settings, few treatment options exist for infants requiring further respiratory support. A bubble bilevel device has been developed to provide nonelectric, time-cycled, pressure-limited respiratory support. We compared the efficacy of bubble bilevel ventilation with conventional mechanical ventilation in sedated rabbits. METHODS: Six adult rabbits under inhaled isoflurane general anesthesia were ventilated by alternating intervals of conventional and bubble bilevel ventilation for three 10−15-min periods. During each period, interval arterial blood gas (ABG) measurements were obtained after at least 10 min on the respective mode of ventilation. RESULTS: The bubble bilevel system was able to deliver the following pressures: 20/7, 15/5, 12/5, 8/5 cm H2O. The estimated differences in arterial blood gas values on bubble bilevel vs. ventilator were as follows (normalized values): pH 7.41 vs. 7.40, pCO2 37.7 vs. 40, pO2 97.6 vs. 80. In addition, the bubble bilevel ventilation delivered consistent pressure waveforms without interruption for over 60 min on two rabbits. CONCLUSION: This study demonstrates promising in vivo results on the efficacy of a novel bubble bilevel device, which may prove 1234567890();,: useful for infants in respiratory distress.
    [Show full text]
  • CELEBRATION of SCIENCE
    CELEBRATION of SCIENCE COVID Lessons Learned: Scientific and Community Impact 72ND MEETING OF THE MGH SCIENTIFIC ADVISORY COMMITTEE Wednesday, April 7 & Thursday, April 8, 2021 Table of Contents 2–3 90–229 Meeting Agenda Department Reports 4 90 Anesthesia, Critical Care and P ain Medicine Martin Research Prizes 94 Cancer Center 5 98 The Consortia for Improving Medicine with Innovation Howard M. Goodman Fellowship & Technology 6–7 102 Dermatology SAC Membership 106 Emergency Medicine 110 Medicine 8–9 122 Molecular Biology ECOR Membership 126 Neurology 10–61 132 Neurosurgery MGRI Executive Report 136 Nursing 140 Obstetrics and Gynecology 62–69 148 Ophthalmology Programmatic Report 154 Oral and Maxillofacial 62 Center for Diversity Surgery and Inclusion (CDI) 158 Orthopaedics 64 Center for Faculty 168 Otolaryngology, Head and Development (CFD) Neck Surgery 176 Pathology 70–89 180 Pediatrics Thematic Center Report 194 Psychiatry 70 Center for Computational 198 Radiation Oncology and Integrative Biology 204 Radiology 74 Center for Genomic 208 Ragon Institute of MGH, Medicine MIT & Harvard 78 Center for Regenerative 210 Surgery Medicine 220 Urology 82 Center for Systems Biology 86 Wellman Center for Photomedicine Front cover photo thanks to Dylan Parsons, BS, Ragon Institute of MGH, MIT and Harvard (dylanparsonsphotography.com) Celebration of Science 3 Agenda Wednesday, April 7, 2021 11:00 AM – 1:00 PM Virtual Poster Session 2:00 – 5:00 PM Celebration Of Science Welcome and Opening Remarks Peter L. Slavin, MD, President, MGH ECOR Report David
    [Show full text]
  • General Pediatrics
    Evidence for a Small Baby Unit: Creating Expertise by Experience Michael Stewart, MD 24th Annual Perinatal Partnership Conference September 17-19th, 2017 • I have no conflicts of interest to disclose Goals • Briefly discuss the successes made with extremely premature infants over the last several decades • Review the history of critical care medicine and the creation of specialized ICUs • Highlight the seminal article published in 2015 for the creation of a small baby unit (SBU) as well as other supporting evidence • Outline Greenville Hospital System’s approach to creating a SBU Major Mortality Successes for Extremely Premature Infants Anesth Analg. 2015 Jun; 120(6): 1337–1351. Trends in Extremely Premature Infant Survival from 1993 to 2012 JAMA 2015;314 (10): 1039-1051 Trends in Extremely Premature Infant Morbidity from 1993 to 2012 JAMA 2015;314 (10): 1039-1051 Unique Risks Immunocompromised Intraventricular Skin integrity hemorrhage Respiratory Neurodevelopmental compromise care ELBW Highest risk of Infant/parental mortality Infant bonding Significant Innovations for Extremely Premature Infants Anesth Analg. 2015 Jun; 120(6): 1337–1351. “To know your future, you should study your past.” History of Critical Care • Rationalization of critical care medicine – Seriously ill require closer attention – Advancements in technology requires increasing levels of specialized training • 1850s- Florence Nightingale placed the seriously ill closer to the nursing station for proximity • 1923- Dr Walter Dandy opened a three-bed unit for postoperative
    [Show full text]
  • Bubble CPAP Splitting: Innovative Strategy in Resource-Limited Settings­ Akanksha Verma, Rahul Jaiswal, Kirti M Naranje, Girish Gupta, Anita Singh
    Arch Dis Child: first published as 10.1136/archdischild-2020-320030 on 16 November 2020. Downloaded from Global child health Bubble CPAP splitting: innovative strategy in resource- limited settings Akanksha Verma, Rahul Jaiswal, Kirti M Naranje, Girish Gupta, Anita Singh Neonatology, Sanjay Gandhi ABSTRACT bCPAP is a form of non- invasive respiratory Post Graduate Institute of Background Non- invasive respiratory support for support which is a gentle, simple, safe and effective Medical Sciences, Lucknow, way of respiratory support especially used in infants Uttar Pradesh, India neonates using bubble continuous positive airway pressure (bCPAP) delivery systems is now widespread and children. It acts as a bridge between oxygen Correspondence to owing to its safety, cost effectiveness and easy therapy and invasive ventilation. The feasibility and Dr Kirti M Naranje, Neonatology, applicability. Many innovative solutions have been widespread use of such set- up in resource- limited Sanjay Gandhi Post Graduate suggested to deal with the possible shortage in countries is further supported by its perceived Institute of Medical Sciences, desperate situations like disasters, pandemics and safety, reduced invasiveness and less demanding Lucknow 226014, India; technical skill requirement. drkirtinaranje@ gmail. com resource- limited settings. Although splitting of invasive ventilation has been reported previously, no attempts In the last few years, several new devices with to split non- invasive respiratory support have been alterations in the original design have been described reported. for more widespread use of CPAP in resource- Objective The primary objective was to test the limited settings. However, many such designs use feasibility of splitting the bCPAP assembly using a T- piece a high- resistance interface and narrow expira- splitter in a simulation model.
    [Show full text]
  • CPAP) for Neonatal Care in Public Health Facilities in India: a Cross-­Sectional Cluster Survey
    Open access Original research BMJ Open: first published as 10.1136/bmjopen-2019-031128 on 28 February 2020. Downloaded from Availability and use of continuous positive airway pressure (CPAP) for neonatal care in public health facilities in India: a cross- sectional cluster survey Juan Emmanuel Dewez ,1 Sushma Nangia,2 Harish Chellani,3 Sarah White ,4 Matthews Mathai ,4 Nynke van den Broek4 To cite: Dewez JE, Nangia S, ABSTRACT Strengths and limitations of this study Chellani H, et al. Availability Objectives To determine the availability of continuous and use of continuous positive airway pressure (CPAP) and to provide an overview ► Nationwide assessment of the availability and use of positive airway pressure of its use in neonatal units in government hospitals across (CPAP) for neonatal care continuous positive airway pressure (CPAP) in neo- India. in public health facilities nates in a representative sample of public hospitals Setting Cross- sectional cluster survey of a nationally in India: a cross-sectional in India, through direct hospital site visits. representative sample of government hospitals from cluster survey. BMJ Open ► Our findings apply to government facilities; the avail- across India. 2020;10:e031128. doi:10.1136/ ability and use of CPAP in private hospitals, where a Primary outcomes Availability of CPAP in neonatal units. bmjopen-2019-031128 large proportion of inpatient care is provided in India, Secondary outcomes Proportion of hospitals where Prepublication history and may be different. ► infrastructure and processes to provide CPAP are available. additional material for this ► The standards used to assess the availability of Case fatality rates and complication rates of neonates paper are available online.
    [Show full text]
  • Nicu Guide for Residents
    St. Paul NICU Resident Manual Children’s Hospitals and Clinics of Minnesota St. Paul Campus CHAPTERS I. Introduction II. Respiratory Management III. Fluid-Electrolytes-Nutrition IV. Pharmacology V. Discharge Information VI. Clinical INTRODUCTION FOR RESIDENTS I. Introduction II. Goals of Resident Rotation III. Roles: A. Neonatal Fellow and Attending B. Neonatal Nurse Practitioners C. Pediatric Interns D. Charge Nurses E. Social Workers F. Case Managers IV. Rounds V. Resident Weekend/Workload Expectations VI. Daily Notes VII. Consultations VIII. Consent/Parent Notification IX. Conferences/Didactic Teaching Sessions X. Supplemental Educational Curriculum XI. Infection Control XII. Miscellaneous NICU Information I. INTRODUCTION Welcome to the NICU at Children’s Hospitals and Clinics of Minnesota, St. Paul Campus. We are a regional perinatal center serving primarily the greater St. Paul area, as well as western Wisconsin. Although most of our babies are delivered at United/Children’s Perinatal Center, about 15% of our babies are transported in from other hospitals. We provide level II and level III neonatal diagnostic and supportive care including mechanical ventilation, high frequency ventilation, nitric oxide therapy and pediatric surgery. This does not include ECMO; for this therapy, patients are referred to the NICU at the Minneapolis campus. In addition, we offer a regional Infant Apnea Program and staff the NICU Developmental Follow-Up Clinic. II. GOALS OF RESIDENT ROTATION 1. Understand pathophysiology and treatment of common newborn diseases; 2. Develop procedural skills in newborn resuscitation and emergency intervention; 3. Recognize clinical and laboratory signs of a sick newborn and develop appropriate treatment plans; 4. Recognize common congenital malformations and syndromes; 5.
    [Show full text]
  • SLEEP SUCTIONING CPAP ASTHMA BLOOD GAS SPIROMETRY COPD Ad Page 2 Finally, the First Complete Bubble CPAP System That Is Safe, Effective Andad Easy to Use
    Volume 7 Number 6 December 2012-January 2013 The Journal of Pulmonary Technique SLEEP SUCTIONING CPAP ASTHMA BLOOD GAS SPIROMETRY COPD Ad page 2 Finally, the first complete Bubble CPAP System that is safe, effective andAd easy to use. page 3 Providing world-leading humidification technology while delivering reliable respiratory support. (800) 446-3908 [email protected] For more information on the F&P Bubble CPAP System and FlexiTrunk™ Interface please contact your local Fisher & Paykel Healthcare representative. www.fphcare.com Bubble CPAP Advert.indd 1 14/02/2012 9:05:07 a.m. Volume 7 Number 6 December 2012-January 2013 The Journal of Pulmonary Technique Editorial Hacked and App’d SLEEP SUCTIONING Here’s some interesting items in the news regarding medical devices and CPAP ASTHMA BLOOD GAS information technology: Torie Bosch reports via Slate.com that the GAO has asked SPIROMETRY COPD the FDA to develop a strategy to address information security risks for medical devices. This comes after hackers demonstrated the vulnerability of such devices by hacking into an insulin pump. According to the GAO report, “A denial-of-service attack could be launched using computer worms or viruses that overwhelm a device by excessive communication attempts, making the device unusable by either slowing or blocking functionality or draining a device’s battery.” Medical Vol. 7 No. 6 data generated by the devices could be wiped or stolen and therapies could be December 2012-January 2013 altered. The Slate article noted that most medical devices don’t require passwords, likely because a good security system could slow down medical treatment in case of an emergency.
    [Show full text]
  • Bubble Nasal CPAP Manual
    1 Bubble nasal CPAP manual Riyadh AL-Kharj Hospital Programme Neonatal intensive care 2005 Amer Ammari, MB, BS Fawaz Kashlan, MD Faisal Ezzedeen, MD Atyah AL-Zahrani, MD John Kawas, RRT M.A. Majeed-Saidan, MB. Ch.B., FRCP Adapted from the “NCPAP Education and training manual” By J.M. Conner, R. de Klerk and A. de Klerk. PREFACE Respiratory Distress Syndrome (RDS) is due to a deficiency of pulmonary surfactant. Seventy one % of very low birth weight infants had RDS, and 35% of them still required oxygen at 36 weeks adjusted age (Vermont Oxford Network 2001). Along with significant mortality, RDS is associated with significant morbidity and high costs to society. Pulmonary surfactant lines the surface of the alveoli in the lung, thereby reducing surface tension and preventing alveolar collapse. Surfactant deficiency results in progressive atelectasis of the alveoli, decreased pulmonary compliance, increased work of breathing, respiratory failure, and lung injury. The earlier the gestational age, at which birth occurs, the higher the risk that severe respiratory distress syndrome will develop. Historically, conventional therapy for this disorder has consisted of continuous positive airway pressure (CPAP) or mechanical ventilation, along with appropriate supportive care. In the past decade, surfactant replacement has led to significant improvements in survival, particularly for infants less than 1000 grams. However, attempts to treat RDS may lead to lung injury, and secondary complications including bronchopulmonary dysplasia (BPD) and chronic lung 2 disease (CLD). This lung injury is thought to result from the effect of mechanical injury due to assisted ventilation, oxygen toxicity, and lung inflammation among other factors.
    [Show full text]
  • Efficacy and Safety of CPAP in Low- and Middle-Income Countries
    OPEN Journal of Perinatology (2016) 36, S21–S28 © 2016 Nature America, Inc. All rights reserved 0743-8346/16 www.nature.com/jp SYSTEMATIC REVIEWS Efficacy and safety of CPAP in low- and middle-income countries A Thukral, MJ Sankar, A Chandrasekaran, R Agarwal and VK Paul We conducted a systematic review to evaluate the (1) feasibility and efficacy and (2) safety and cost effectiveness of continuous positive airway pressure (CPAP) therapy in low- and middle-income countries (LMIC). We searched the following electronic bibliographic databases—MEDLINE, Cochrane CENTRAL, CINAHL, EMBASE and WHOLIS—up to December 2014 and included all studies that enrolled neonates requiring CPAP therapy for any indication. We did not find any randomized trials from LMICs that have evaluated the efficacy of CPAP therapy. Pooled analysis of four observational studies showed 66% reduction in in-hospital mortality following CPAP in preterm neonates (odds ratio 0.34, 95% confidence interval (CI) 0.14 to 0.82). One study reported 50% reduction in the need for mechanical ventilation following the introduction of bubble CPAP (relative risk 0.5, 95% CI 0.37 to 0.66). The proportion of neonates who failed CPAP and required mechanical ventilation varied from 20 to 40% (eight studies). The incidence of air leaks varied from 0 to 7.2% (nine studies). One study reported a significant reduction in the cost of surfactant usage with the introduction of CPAP. Available evidence suggests that CPAP is a safe and effective mode of therapy in preterm neonates with respiratory distress in LMICs. It reduces the in-hospital mortality and the need for ventilation thereby minimizing the need for up-transfer to a referral hospital.
    [Show full text]
  • Queensland Clinical Guideline: Respiratory Distress and CPAP
    Queensland Health Clinical Excellence Queensland Maternity and Neonatal Clinical Guideline Respiratory distress and CPAP Queensland Clinical Guideline: Respiratory distress and CPAP Document title: Respiratory distress and CPAP Publication date: June 2020 Document number: MN20.3-V8-R25 The document supplement is integral to and should be read in conjunction with Document supplement: this guideline. Amendments: Full version history is supplied in the document supplement. Amendment date: Full review of original document published in October 2014 Replaces document: MN14.3-V7-R25 Author: Queensland Clinical Guidelines Health professionals in Queensland public and private maternity and neonatal Audience: services. Review date: June 2025 Queensland Clinical Guidelines Steering Committee Endorsed by: Statewide Maternity and Neonatal Clinical Network (Queensland) Email: [email protected] Contact: URL: www.health.qld.gov.au/qcg Cultural acknowledgement We acknowledge the Traditional Custodians of the land on which we work and pay our respect to the Aboriginal and Torres Strait Islander elders past, present and emerging. Disclaimer This guideline is intended as a guide and provided for information purposes only. The information has been prepared using a multidisciplinary approach with reference to the best information and evidence available at the time of preparation. No assurance is given that the information is entirely complete, current, or accurate in every respect. The guideline is not a substitute for clinical judgement, knowledge
    [Show full text]